Chemical Executives Deal with Tariffs (ICIS Chemical Business May 9 – May 15, 2025)
ICIS Chemical Business reports on panel discussion (Apollo, Dow and Westlake executives) moderated by Peter Young on April 30, 2025.
Chemical Debt Financing Perks Up (ICIS Chemical Business February 21 – February 27, 2025)
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have rebounded chemical debt financings and the outlook for 2025.
Biopharma Business Check – Financing and Review (Pharmaceutical Executive, February 2025)
Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.
Global M&A Treads Water
Young & Partners shares proprietary analysis of the Chemicals M&A market and their outlook for 2025.
Divestitures in the Current Environment
Young & Partners shares proprietary analysis of the Chemicals M&A market and proposes questions for Chemicals owners to think over as significant asset rationalization occurs globally.
Reflections on 2024 and Outlook – Stock Market and Funding
Young & Partners shares proprietary analysis of the stock market and funding environment in Biotech and Pharma and the outlook for 2025.
Reflections on 2024 and Outlook – Senior Management Approach to M&A
Young & Partners shares proprietary analysis and outlook of how managers and executive should approach Biotech and Pharma M&A market in 2025.
Reflections on 2024 and Outlook – Biotech and Pharma M&A
Young & Partners shares proprietary analysis of the global disruptions and uncertainties that have affected the Biotech and Pharma M&A market in 2024 and the outlook for 2025.
Young & Partners Pharmaceutical Executive Summit 2024: The Impact of Artificial Intelligence on the Creation of Medicines (Pharmaceutical Executive)
Pharmaceutical Executive shares Fred Hassan's and Najat Khan's comments made at the 2024 Young & Partners Pharmaceutical Executive Summit. https://www.pharmexec.com/view/young-partners-pharmaceutical-executive-summit-2024-impact-artificial-intelligence-creation-medicines
Young & Partners Pharmaceutical Executive Summit 2024: Brave New World – Where Are We Heading? (Pharmaceutical Executive)
Pharmaceutical Executive shares Peter Marks' comments made at the 2024 Young & Partners Pharmaceutical Executive Summit. https://www.pharmexec.com/view/young-partners-pharmaceutical-executive-summit-2024-brave-new-world-where-heading-